the benefits, once the medication is stopped, are quickly negated, and people face the same issues they experienced prior to starting, including increased appetite and reduced satiety signals.
addressing obesity from various angles
the study results show that addressing obesity must come from multiple angles: medications, behavioural, and lifestyle components. because if people stop the drugs and they regain the weight, they’ll be back at square one.
one way to encourage better adherence is to also incorporate coping skills in people who take glp-1s. when people try to lose weight through natural methods, they are often taught skills to manage hunger during weight loss, whereas a strictly medical approach doesn’t.
combining medication with these supports that help people in behavioural lifestyle programs only can make it better for people who cannot afford and cannot tolerate glp-1s.
things are changing in the glp-1 game, though, with newer medications being made that could provide better access financially, as well as reduce the side effects that many experience, which leads to stopping the medication.
insurance providers adding behavioural programs to their coverage can also help people living with obesity so they can participate in various aspects of care, fostering better weight loss success and reduced health risks associated with obesity.